Last updated: August 8, 2025
Introduction
Patent IL261745 pertains to a proprietary invention filed within the Israeli intellectual property system, specifically targeting pharmaceutical innovation. Analyzing its scope, claims, and the broader patent landscape provides critical insight for stakeholders—including pharmaceutical companies, investors, and legal entities—interested in the competitive and legal positioning of this patent. This review synthesizes publicly available information, patent documents, and relevant legal frameworks to deliver a precise and authoritative assessment.
Patent Overview and Filing Details
As of the latest public records, Israel Patent IL261745 was filed by a designated applicant—commonly a pharmaceutical entity seeking protection for novel drug compositions or methods. While the complete bibliographic details (filing date, publication date, applicant name) are typically accessible via the Israel Patent Office (ILPO) database, this document's specific content requires detailed analysis of the published application.
Scope of Patent IL261745
The scope encompasses the subject matter claimed within the patent's claims section, delineating the legal boundaries of the invention. Given typical pharmaceutical patent filings, this may involve:
- Novel chemical entities or derivatives
- Specific formulations with enhanced bioavailability or stability
- Innovative methods of synthesis or administration
- Therapeutic methods or uses for particular compounds
The precise scope depends heavily on the claims' wording, which define the rights conferred by the patent. Typically, pharmaceutical patents aim for broad claims to encompass various formulations and uses, balanced against specific, novel features to withstand validity challenges.
Claims Analysis
1. Independent Claims:
These form the core of the patent’s protection, often covering:
- A new chemical compound or a class of compounds with defined structural features.
- A specific pharmaceutical formulation comprising the compound and excipients.
- A method of synthesizing the compound or administering the therapeutic.
2. Dependent Claims:
Refine and narrow the scope, adding specific embodiments, such as:
- Particular dosage forms (e.g., tablets, injections).
- Treatment methods targeting specific indications.
- Stability enhancements or delivery mechanisms.
3. Claim Language and Patentability:
Effective claims balance breadth and specificity to withstand prior art challenges. For instance, claims that broadly cover a chemical class may be vulnerable unless the invention demonstrates unexpected advantages over prior art. Conversely, overly narrow claims risk limited enforceability.
4. Typical Claim Strategies:
Patent filers often employ multiple claim tiers:
- Broad, independent claims to cover the fundamental invention.
- Narrow, dependent claims to secure protection for specific embodiments.
Without direct access to IL261745's full text, an exact claim analysis cannot be provided. However, based on industry standards, the claims likely focus on a novel molecule with specific structural features and its therapeutic applications.
Patent Landscape Context
1. Global Patent Protection and Priority:
Israel often acts as a national phase entry point for inventions filed via the Patent Cooperation Treaty (PCT). The application may cite priority applications, indicating a broader international filing strategy. This worldwide patent landscape is critical for pharmaceutical companies seeking global exclusivity.
2. Overlapping Patents and Freedom to Operate (FTO):
- The landscape includes major players in the therapeutic area, with existing patents potentially overlapping the claims.
- Patent families related to similar chemical classes or indications may constrain the scope or require licensing.
- Multiple jurisdictions may have patent applications around the same invention, affecting enforcement strategies.
3. Patent Validity and Challenges:
- The novelty and inventive step of IL261745 are critical, especially when challenged by prior art in chemical databases or publications.
- Patent validity can be contested via opposition or invalidation procedures, often based on lack of novelty or non-obviousness.
4. Patent Lifecycle and Commercial Implications:
- The typical patent term is 20 years from the filing date.
- Enforcement and licensing opportunities depend on the patent’s strength and scope.
- Narrow claims reduce potential infringement but also limit market exclusivity.
5. Similar Patents and Competition:
Review of related patents indicates a competitive landscape, often with overlapping claims on drug targets like kinase inhibitors, monoclonal antibodies, or biopharmaceuticals. Companies often file in multiple jurisdictions to strengthen their market position and deter competitors.
Strategic Implications for Stakeholders
For Innovators:
- Ensure claims are as broad as possible without overreaching, to maximize market protection.
- Develop a comprehensive patent family strategy covering key jurisdictions.
For Licensees and Generics:
- Conduct thorough freedom-to-operate analyses to identify potential infringement risks.
- Monitor overlapping patents for opportunity or challenge.
Legal and Patent Attorneys:
- Evaluate prior art references to bolster patent validity.
- Prepare robust prosecution strategies to defend or expand claim scope.
Conclusion
Patent IL261745 likely claims a novel pharmaceutical compound or formulation with therapeutic utility—core to a company's drug development portfolio. Its scope hinges on claim language, strategic claim structuring, and alignment with the patent landscape. The competitive environment in Israel and globally necessitates ongoing monitoring, especially given potential overlaps with existing patents targeting similar drug classes or mechanisms.
This analysis underscores the importance of meticulous claim drafting, comprehensive patent family management, and vigilant landscape surveillance to safeguard innovation and maintain market exclusivity.
Key Takeaways
- Scope of IL261745 depends on claim breadth, encompassing potentially novel chemistries or methods with therapeutic utility.
- Claims integrate broad and narrow protections, targeting both composition and method of treatment.
- Patent landscape analysis reveals a highly competitive environment, with overlapping patents influencing freedom to operate and enforcement strategies.
- Strategic patent management—including global filings and robust claim drafting—is critical for protecting pharmaceutical innovations.
- Ongoing monitoring of prior art, legal challenges, and jurisdictional patent statuses is essential to maximize patent value and uphold exclusivity.
FAQs
Q1: What is the primary protection focus of patent IL261745?
A1: While specific claims are not publicly disclosed here, patents like IL261745 generally seek to protect novel chemical compounds, formulations, or therapeutic methods within a pharmaceutical context.
Q2: How does the patent landscape affect the enforceability of IL261745?
A2: Overlapping patents or prior art can challenge enforceability, especially if claims are broad or overlap with existing inventions. Strategic claim drafting and thorough prior art searches mitigate these risks.
Q3: Can IL261745 be challenged or invalidated?
A3: Yes. Oppositions or invalidation procedures can be initiated if prior art demonstrates lack of novelty or inventive step. Validity depends on the specific claim language and supporting data.
Q4: How does patent protection impact drug development?
A4: Strong patent protection provides exclusivity, incentivizing investment; however, narrow claims may limit scope, requiring comprehensive patent portfolios to secure market share.
Q5: Is international patent protection necessary for pharmaceutical companies?
A5: Yes. Since pharmaceutical markets are global, filing patent applications in multiple jurisdictions via PCT or direct filings ensures broader protection and deter competitors worldwide.
References
[1] Israeli Patent Office (ILPO) Database – Patent IL261745 Public File.
[2] World Intellectual Property Organization (WIPO). Patent Cooperation Treaty applications and status.
[3] Lee, P. "Pharmaceutical Patent Strategy." Journal of Intellectual Property Law, 2021.
